Flow cytometry analysis indicates that the percentage of CD133+ cells present in the cell suspension injected in the SCID mice directly correlated to the tumor forming ability of the cells (Figure 5A) suggesting therefore that, contrary to what previously reported [7, 8], CD133 may help to identify subsets of CSCs in RCC. The gene discussed is PROM1; the disease is neoplasm.